Loading...
XTAI
1760
Market cap149mUSD
Oct 08, Last price  
55.70TWD
1D
2.58%
1Q
-10.45%
Jan 2017
-17.85%
IPO
199.46%
Name

Panion & BF Biotech Inc

Chart & performance

D1W1MN
XTAI:1760 chart
P/E
25.11
P/S
2.31
EPS
2.22
Div yield, %
3.23%
Shrs. gr., 5y
1.91%
Rev. gr., 5y
5.64%
Revenues
2.06b
+1.66%
559,396,000524,779,000584,249,000674,896,000857,082,0001,014,406,0001,205,065,0001,049,246,0001,212,478,0001,408,741,0001,573,944,0001,568,637,0001,901,211,0002,398,648,0001,881,875,0002,029,645,0002,063,391,999
Net income
190m
+52.72%
5,088,000-39,305,000-36,260,000-40,562,00018,149,00048,269,00072,996,00089,720,00090,539,000159,171,000161,329,00027,901,000104,402,000182,345,00077,219,000124,523,000190,169,000
CFO
299m
-14.94%
76,978,000-13,895,000-36,120,0003,958,00086,225,00076,111,00058,304,000177,217,000113,973,00078,584,00090,984,000-14,555,000401,225,000489,872,000177,418,000351,188,000298,707,000
Dividend
Jun 11, 20262 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Panion & Bf Biotech Inc. is a biopharmaceutical firm operating in Taiwan, engaged in the production and distribution of a diverse range of pharmaceutical goods. Its offerings cater to several key therapeutic and wellness segments, including medical aesthetics, renal care, respiratory health, and gastrointestinal support. Beyond these, the company also provides oral medications, topical treatments, and an array of hygiene products like hand, mechanical, and skin disinfectants, alongside body lotions. Additionally, Panion & Bf Biotech supplies veterinary health solutions, notably surgical and dermatological prescriptions for animals. Established in 1976, the company maintains its corporate headquarters in Taipei, Taiwan.

Key people

Chung-Ming Chiang
General Manager, Director · since 1998
Yu-Sheng Hsueh
Deputy General Manager · since 2023
Chun-Ping Lu
Deputy General Manager · since 2017
Chung-Chi Tsai
Deputy General Manager-Operation Management, Corporate Governance Officer · since 2024
Feng-Jen Wang
Deputy General Manager · since 2000
Mei-Lun Chiu
Head of Accounting · since 2021
Li-Chiou Chang
Chairman of the Board · since 2016
Pa-Chuan Chen
Director · since 2022
De-Fu Hsieh
Director · since 2001
Weng-Houng Huang
Director · since 2016
Jyh-Ming Lin
Director · since 2019
Tien-szu Tseng
Director · since 2025
Ryh-Yan Chang
Independent Director · since 2014
Yun-Peng Chang
Independent Director · since 2025
Jiin-Shian Chen
Independent Director · since 2014
Chung Yen Lee
Independent Director · since 2025
URL
https://www.pbf.com.tw/
IPO date
Jun 14, 2004
Employees
Domiciled in
TW
Incorporated in
TW
Legal address
16TH FLOOR
3 PARK STREET NANGANG DISTRICT
TAIPEI, TPE 11571
TW
Headquarters
16TH FLOOR
NO. 3, YUANQU STREET NANGANG DISTRICT
TAIPEI, TPE 11571
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT